Passage Bio
Biotechnology, 2001 Market St, Philadelphia, Pennsylvania, 19103, United States, 51-200 Employees
Phone Number: 26********
Who is PASSAGE BIO
We are a genetics medicine company based in Philadelphia, PA, a city with a rich history of scientific discovery and medical advancement. As a leading developer of cutting-edge therapeuti...
Read More
-
Headquarters: 2001 Market St, Philadelphia, Pennsylvania, 19103, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
Does something look wrong? Fix it. | View contact records from PASSAGE BIO
Passage Bio Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Passage Bio
Answer: Passage Bio's headquarters are located at 2001 Market St, Philadelphia, Pennsylvania, 19103, United States
Answer: Passage Bio's phone number is 26********
Answer: Passage Bio's official website is https://passagebio.com/home/default.aspx
Answer: Passage Bio's revenue is $50 Million to $100 Million
Answer: Passage Bio's SIC: 2836
Answer: Passage Bio has 51-200 employees
Answer: Passage Bio is in Biotechnology
Answer: Passage Bio contact info: Phone number: 26******** Website: https://passagebio.com/home/default.aspx
Answer: We are a genetics medicine company based in Philadelphia, PA, a city with a rich history of scientific discovery and medical advancement. As a leading developer of cutting-edge therapeutics for disorders of the central nervous system (CNS), we are proud to be a part of this dynamic research community. We are also excited about our new laboratory at the Princeton West Innovation Campus in Hopewell, New Jersey, which will help us evolve the standard for biotech innovation and development. At Passage Bio, we have a bold vision to fulfill the promise of gene therapy and a differentiated approach to gene therapy development through our collaboration with University of Pennsylvania's Gene Therapy Program and Orphan Disease Center. Our deep pipeline of optimized gene therapies for CNS disorders includes lead programs focused on the following devastating diseases: GM1 gangliosidosis Krabbe disease Frontotemporal dementia
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month